|
|
 |
|
| Overview |
| The CD105 antibodies have been designed for the identification and enumeration of human CD105+ cells by flow cytometry or fluorescence microscopy. They are ideally suited for the evaluation of MACS Separations, e.g., human endothelial cells isolated with CD105 MicroBeads. |
| Details |
Background information The CD105 antigen, also known as endoglin, serves as a receptor for the growth and differentiation factors TGF-β1 and TGF-β3. An epitope of CD105 is recognized by the SH-2 antibody1, which was raised against human mesenchymal stromal cells (MSC) that show mesodermal differentiation capacity.2 Therefore, it can be used for studies on mesengenesis. CD105 is also expressed on mature endothelial cells and on some leukemic cells of B lymphoid and myeloid origin. |
| Clone | Isotype |
| 43A4E1 | mouse IgG1 |
| |
| Figure 1 |
| Human peripheral blood mononuclear cells (PBMCs) were spiked with human umbilical vein endothelial cells (HUVECs) and stained with CD105 antibodies conjugated to PE (A) or APC (B) as well as with CD45-FITC and analyzed by flow cytometry using the MACSQuant® Analyzer. Cells labeled with CD105-Biotin (C) were stained with Anti-Biotin-PE as well as CD45-FITC. Cell debris and dead cells were excluded from the analysis based on scatter signals and propidium iodide fluorescence. |
| A |
 |
| B |
 |
| C |
 |
|
|
|
 |
| Favorites / Prices |
Request prices or add products to your favorite list.
|
| Details |
|
| Products |
| CD105-PE, human |
- for 100 tests (1) Download datasheet 130-094-941
|
| CD105-APC, human |
- for 100 tests (1) Download datasheet 130-094-926
|
| CD105-Biotin, human |
- for 100 tests (1) Download datasheet 130-094-916
|
| (1) One test corresponds to fluorescent labeling of up to 107 cells in a total volume of 100 μL. |
|
| References |
| 1. Barry, F. P. et al. (1999) Biochem Biophys Res. Commun. 265: 134–139. |
| 2. Majumdar, M. K. et al. (2000) J. Cell Physiol 185: 98–106. |
|
| MACS Stem Cell newsletter |
|
Stay current with important developments in stem cell research by subscribing to
Stem Cell Updates.
|
|
© 1999 - 2012 Miltenyi Biotec ¦ Terms & conditions ¦ Legal notes
|